Food and Drug Administration
Cardiovascular and Renal Drugs Advisory Committee
April 12, 2002
NDA 20-386/S-028, COZAAR™ Tablets (Losartan Potassium), For the treatment of type 2 diabetic patients with nephropathy
Briefing Information
Sponsor - Merck Research Laboratories pdf
Food and Drug Administration
Medical Review Addendum pdf htm doc
Statistical Review pdf htm doc